Famciclovir and meloxicam combination therapy for functional somatic syndromes
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor meloxicam. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and meloxicam.
1. A method to treat a subject afflicted with irritable bowel syndrome, the method comprising
administering to the subject in need thereof a therapeutically-effective combination of famciclovir and meloxicam,
wherein the amount of famciclovir is administered in a total daily dose range from about 250 mg to about 2000 mg, and
wherein the amount of meloxicam is administered in a total daily dose range from about 7.5 mg to about 30 mg.
2. A method to treat a subject afflicted with a combination of fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome, coexistent in the subject, the method comprising
administering to the subject in need thereof a therapeutically-effective combination of famciclovir and meloxicam,
wherein the amount of famciclovir is administered in a total daily dose range from about 250 mg to about 2000 mg, and
wherein the amount of meloxicam is administered in a total daily dose range from about 7.5 mg to about 30 mg.